Equifax Q2 Earnings & Revenues Surpass Estimates, Increase Y/Y

22.07.25 18:09 Uhr

Werte in diesem Artikel
Aktien

214,00 EUR -16,00 EUR -6,96%

76,50 EUR 0,50 EUR 0,66%

Indizes

6.309,6 PKT 4,0 PKT 0,06%

Equifax Inc. EFX has reported impressive second-quarter 2025 results, wherein earnings and revenues outpaced the Zacks Consensus Estimate.EFX’s adjusted earnings were $2 per share, surpassing the Zacks Consensus Estimate by 4.2% and increasing 9.9% from the year-ago quarter. Total revenues of $1.5 billion beat the consensus estimate by 1.5% and increased 7.4% on a year-over-year basis.Equifax shares gained 1.8% in the year-to-date period compared with the 9.7% drop of the industry and  6.5% growth of the Zacks S&P 500 composite.Equifax, Inc. Price, Consensus and EPS Surprise  Equifax, Inc. price-consensus-eps-surprise-chart | Equifax, Inc. QuoteSegmental Information for EFXRevenues in the Workforce Solutions segment totaled $662.1 million, rising 8% from the year-ago quarter. The metric surpassed our estimation of $652.8 million. Within the segment, Verification Services’ revenues of $567.1 million increased 10% from the year-ago quarter. Employer Services’ revenues of $95 million dropped 2% on a year-over-year basis.The USIS segment’s revenues were $521.5 million, up 9% from the year-ago quarter and beat our estimated figure of $509.2 million. Within the segment, Online Information Solutions’ revenues of $457.8 million rose 9% year over year. Financial Marketing Services’ revenues were $63.7 million, increasing 6% from the year-ago quarter.Revenues in the International division amounted to $353.4 million, up 4% and 6% year over year on a reported and local-currency basis, respectively. The metric missed our estimation of $361.3 million.Latin America’s revenues of $99.6 million increased 2% from the year-ago quarter on a reported basis and 11% on a local-currency basis. Revenues from Europe amounted to $99.2 million, up 12% on a reported basis and 6% on a local-currency basis. Revenues from the Asia Pacific were $85.3 million, increasing 1% from the year-ago quarter on a reported basis and 4% on a local-currency basis. Canada’s revenues of $69.3 million were flat with the year-ago quarter on a reported basis and gained 1% on a local-currency basis.Equifax’s Operating ResultsAdjusted EBITDA in the second quarter of 2025 amounted to $499.3 million, indicating 9.1% growth on a year-over-year basis. The adjusted EBITDA margin was 32.5%, up 50 basis points from the year-ago quarter.Workforce Solutions’ adjusted EBITDA margin was 53.3% compared with 52.8% in a year-ago quarter. The adjusted EBITDA margin for the USIS division was 35% compared with 33.2% in the second quarter of 2024. The adjusted EBITDA margin for the international segment was 26.4% in comparison with 25.6% in the year-ago quarter.EFX’s Balance Sheet & Cash FlowEquifax exited the second quarter with cash and cash equivalents of $189 million compared with $195.2 million at the end of the first quarter of 2025. The company has a long-term debt of $4.1 billion compared with $4.3 billion in the preceding quarter.Cash generated by operating activities amounted to $361.1 million, whereas capital expenditure totaled $122.2 million. The company distributed $62 million as dividends in the quarter.Equifax’s Q3 & 2025 OutlookFor the third quarter of 2025, the company raised its revenue expectation to $1.505-$1.535 billion from the preceding quarter’s view of $1.495-$1.525 billion. The mid-point ($1.52 billion) of the guided range is higher than the Zacks Consensus Estimate of $1.51 billion. EFX hiked the adjusted EPS outlook to $1.87-$1.97 from the preceding quarter’s view of $1.85-$1.95. The mid-point ($1.92) of the guided range is in line with the Zacks Consensus Estimate.For 2025, Equifax has raised its revenue guidance to $5.97-$6.04 billion from the preceding quarter’s view of $5.91-$6.03 billion. The mid-point ($6.01 billion) of the guided range meets the Zacks Consensus Estimate. The company raised adjusted EPS to $7.33-$7.67 from $7.25-$7.65 provided in the preceding quarter. The mid-point ($7.5) of the guided range is lower than the Zacks Consensus Estimate for earnings of $7.62 per share.Equifax carries a Zacks Rank #3 (Hold) at present. You can see the complete list of today’s Zacks #1 Ranked (Strong Buy) stocks here.Earnings SnapshotFactSet FDS reported the results for the third quarter of fiscal 2025.FDS’s earnings per share of $4.27 missed the consensus mark by a slight margin and decreased 2.3% from the year-ago quarter. Revenues of $585.5 million beat the Zacks Consensus Estimate by a slight margin and gained 5.9% from the year-ago quarter.Paychex, Inc. PAYX posted impressive fourth-quarter fiscal 2025 results.PAYX’s fiscal fourth-quarter earnings of $1.19 per share beat the Zacks Consensus Estimate by a slight margin and increased 6.3% from the year-ago quarter. Total revenues of $1.4 billion surpassed the consensus estimate by a slight margin and gained 10% from the year-ago quarter.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Paychex, Inc. (PAYX): Free Stock Analysis Report Equifax, Inc. (EFX): Free Stock Analysis Report FactSet Research Systems Inc. (FDS): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Equifax und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Equifax

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Equifax

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Equifax Inc.

Wer­bung

Analysen zu Equifax Inc.

DatumRatingAnalyst
05.02.2019Equifax HoldDeutsche Bank AG
26.10.2018Equifax Equal WeightBarclays Capital
14.12.2017Equifax Equal WeightBarclays Capital
13.11.2017Equifax HoldStifel, Nicolaus & Co., Inc.
13.11.2017Equifax Sector PerformRBC Capital Markets
DatumRatingAnalyst
13.11.2017Equifax HoldStifel, Nicolaus & Co., Inc.
19.09.2017Equifax OutperformRBC Capital Markets
22.03.2017Equifax BuyStifel, Nicolaus & Co., Inc.
10.02.2017Equifax OverweightBarclays Capital
10.02.2017Equifax BuyStifel, Nicolaus & Co., Inc.
DatumRatingAnalyst
05.02.2019Equifax HoldDeutsche Bank AG
26.10.2018Equifax Equal WeightBarclays Capital
14.12.2017Equifax Equal WeightBarclays Capital
13.11.2017Equifax Sector PerformRBC Capital Markets
23.10.2017Equifax Sector PerformRBC Capital Markets
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Equifax Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen